Latest News on Dr Reddys Lab
Showing of 0 - 10 from 18 results
Dr Reddys Lab - Total results - 18
Jul 16, 2018
Dr Reddy's shares tank nearly 11% after US District Court's decision on sale of productShares of Dr Reddy's Laboratories on Monday slumped nearly 11 percent following a decision made by the District Court of New Jersey with respect to further sale and commercialisation of its product in the US
Apr 04, 2018
True tech power comes from harvesting patents: ISRO, Cipla and Biocon show the way for future entrepreneursIs there an entrepreneur out there who has the money and the audacity to gamble on a new future? India could do with some audacious private entrepreneurs.
Nov 21, 2017
Sensex, Nifty close high for fourth day in a row on strong global cues; pharma stocks in demandAccording to market observers, the key indices discarded the previous day's lacklustre performance to trade with substantial gains although some gains were capped as investors booked profits in banking and realty stocks
Nov 17, 2017
Prescient messages about the revenues of various Indian companies appear on private WhatsApp groups: ReportThe post that circulated in the WhatsApp group three days earlier had predicted a loss of more than 500 million rupees for Dr. Reddy's Laboratories Limited.
Nov 02, 2017
Dr Reddy's Lab, Sun Pharma, Glenmark among 18 under US lens on price fixing complaintIn July 2014, the state of Connecticut started a probe -- later joined by other states -- into suspicious price increase of certain generics by up to 1,000 percent or more
Jul 27, 2017
Sensex hits new high, Nifty retreats from record level on F&O expiry daySensex closed marginally higher by 0.84 point at 32,383.30.
Jul 24, 2017
India Inc salary mismatch: Private CEOs get up to 1,200 times more than staff, PSU chiefs just 3-4 timesTCS saw the ratio between top-paid executive pay and the median employee remuneration rise to 515 times (from 460 times in previous year), while the same for Lupin stood at 1,263 times (though down from 1,317 times) for Chairman.
Sep 16, 2016
Dr Reddy's inks pact with US-based Amgen to market three drugs in IndiaUnder the terms of collaboration, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India
Feb 01, 2016
Now, IPCA Labs gets warning letter from USFDA for manufacturing lapses at 3 plantsThe plants have already been banned from supplying to the United States after the FDA inspected them in July 2014, January 2015 and March 2015
Dec 31, 2015
Warning letters for pharma cos galore: Now Cadila Healthcare faces USFDA heat, stock tanks 16%The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility